The PhD program has established international agreements for the Biomedical and Pharmaceutical Sciences curricula with two partner universities: Taipei Medical University (Asia) and the University of Porto (Europe, until A.Y. 2024-2025). These agreements enable PhD candidates to obtain an international double degree.